• SENSEX 76,617.44
    592.93 (+0.78%)
  • BANKNIFTY 51,348.05
    520.55 (+1.02%)
  • IndusInd Bank
    708.45 1,576.00(%)
  • Kalyan Jewellers
    519.15 794.60(%)
  • Dr Lal Pathlabs
    2,508.00 3,645.00(%)
  • ICICI BLR Growth
    1,003.14 1,001.47(%)
  • Vodafone Idea
    8.33 19.15(%)
  • Bharat Electron
    274.50 204.00(%)
  • Quadrant Future
    605.00 743.45(%)
  • Zomato Ltd
    212.60 304.50(%)
  • SRF
    2,986.25 3,074.95(%)
  • Bengal & Assam
    7,450.00 11,498.90(%)
  • ICICI Bank
    1,338.00 1,372.50(%)
  • Mazagon Dock
    2,610.00 2,929.98(%)
  • Suzlon Energy
    57.74 86.04(%)
  • SpiceJet
    46.10 79.90(%)
  • Dixon Technolog.
    13,485.00 19,149.80(%)
  • Adani Green
    944.95 2,173.65(%)
  • Aegis Logistics
    830.35 1,035.70(%)
  • Hind.Aeronautics
    4,252.00 5,675.00(%)
  • M & M
    2,660.50 3,276.30(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Marksans Pharma Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3285.0
  • ISIN : INE750C01026
225.22 3 (1.46%)
  • As on 03 Apr 2025 (EOD)

  • Today’s Low

    216.92

  • Today’s High

    226.50

  • Open

    222.00

  • Perv Close

    221.97

  • 52W Low

    130.00

  • 52W High

    358.70

Key Indicators

  • P/E(TTM)

    55.75

  • Mar.Cap (₹Cr.)

    10,206.15

  • Div & Yield %

    0.27

  • Book Value(₹)

    28.49

  • Debt-Equity Ratio

    1.46

  • AGM Date

    02-Apr-2025

  • EPS

    4.05

  • P/E Ratio

    55.75

Financials Ratios

  • Debt-Equity Ratio

    0.10

  • Mar.Cap (₹Cr.)

    10,206.15

  • RONW (%)

    16.53

  • ROCE (%)

    20.78

Score Board

  • Equity (₹ in Cr.)

    45.32

  • BV (₹)

    28.50

  • Sales( ₹ in Cr.)

    853.27

  • NP (in Cr.)

    133.69

  • NP Var(%)

    30.0

  • Div%

    60.0

  • CPS (₹)

    3.60

  • EPS (₹)

    3.00

  • Traded Value (₹ in Lakhs)

    10,232.44

  • 52 Week High

    358.70

  • 52 Week Low

    130.00

  • Price BSE

    226.0

  • Price NSE

    225.00

  • Market Capital( in Cr.)

    10,232.44

  • P/C Ratio

    62.90

  • P/E Ratio

    76.60

  • Price Vs.BV

    3.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 853.27 655.20 658.29 599.55 433.42 424.16
Excise Duty 850.06 652.68 647.57 591.74 428.54 411.42
Net Sales 853.27 655.20 658.29 599.55 433.42 424.16
Other Income 62.07 60.48 42.25 31.16 0.17 7.93
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 915.35 715.69 700.54 630.70 433.59 432.09
EXPENDITURE :
Raw Materials 850.06 652.68 647.57 591.74 428.54 411.42
Power & Fuel Cost 850.06 652.68 647.57 591.74 428.54 411.42
Employee Cost 77.19 56.09 60.46 54.64 48.51 46.33
Other Manufacturing Expenses 8.56 15.89 22.22 15.31 10.70 14.38
Selling & Administrative Expenses 81.00 61.54 67.57 60.08 43.86 47.18
Miscellaneous Expenses 8.56 15.89 22.22 15.31 10.70 14.38
Less : Pre-operative Expenses Capitalised :
Total Expenditure 743.45 583.65 566.03 506.37 380.86 376.08
Operating Profit 67.65 35.34 16.74 17.89 13.44 16.59
Interest 0.99 3.61 3.80 5.35 7.29 6.56
Gross Profit 171.89 132.04 134.51 124.33 52.73 56.01
Depreciation 29.13 16.74 17.66 15.19 11.64 8.69
Profit Before Tax 171.89 132.04 134.51 124.33 52.73 56.01
Tax 37.01 30.35 30.01 28.19 11.60 12.11
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.68 -0.17 0.50 -2.24 3.68 1.00
Reported Net Profit 133.76 102.87 103.99 98.38 37.90 43.62
Extraordinary Items 171.89 132.04 134.51 124.33 52.73 56.01
Adjusted Net Profit 133.76 102.87 103.99 98.38 37.90 43.62
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 27.19 22.66 10.23 10.23 4.09 2.05
P & L Balance carried down 133.76 102.87 103.99 98.38 37.90 43.62
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 60.00 50.00 25.00 25.00 10.00 5.00
Dividend Per Share(Rs) 0.60 0.50 0.25 0.25 0.10 0.05
Earnings Per Share-Unit Curr 2.95 2.48 2.54 2.40 0.93 1.07
Book Value 27.19 22.66 10.23 10.23 4.09 2.05
Book Value(Adj)-Unit Curr 27.19 22.66 10.23 10.23 4.09 2.05

Shareholding Pattern

  • Promoter Group

    43.87%

  • Public Share Holding

    56.13%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 198,822,009 43.87 198,822,009 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 198,822,009 43.87 198,822,009 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 49,324,324 10.88 49,324,324 1
Financial Institutions / Banks 2,911 0.00 911 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 50,176,150 11.07 50,176,150 129
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 14,259,996 3.15 14,259,996 9
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 5,215,705 1.15 5,215,705 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 118,979,086 26.26 118,977,086 149
2] Non Institution
Bodies Corporate 5,659,138 1.25 5,658,138 808
Clearing Members 140,080 0.03 140,080 47
Directors of their Relatives 0 0.00 0 0
Employees 4,045 0.00 4,045 5
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 6,281,644 1.39 6,281,644 4,235
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 3,471,227 0.77 3,471,227 2,783
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 16,992,098 3.75 16,992,098 30
Individuals holding nominal share capital up to Rs. 1 lakh 101,902,357 22.49 101,633,537 251,744
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 77,671 0.02 77,671 8
Others 827,790 0.18 827,790 1
Sub Total 135,362,651 29.87 135,092,831 259,662
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 453,163,746 100.00 452,891,926 259,813

Company Background

Marksans Pharma LtdPharmaceuticals - Indian - Formulations

  • Marksans Pharma Ltd
  • BSE Code : 3285.0
  • ISIN : INE750C01026

  • Incorporation Year

    1992

  • Registered Office

    11th Flr GRANDEUR Oshiwara
    Veera Desai Extn Rd Andheri(W), Mumbai,
    Maharashtra-400053

  • Telephone

    91-22-40012000

  • FAX

    91-22-40012011

  • Chairman

    Mark Saldanha

  • Managing Director

    Mark Saldanha

  • Company Secretary

    Harshavardhan Panigrahi

  • Auditor

    MSKA & Associates

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No 56-2 ,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Marksans Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Marksans Pharma 225.80 915.35 853.27 55.75 14.67
Abbott India 29,572.60 6,097.18 5,848.91 47.09 44.71
Astrazeneca Phar 8,100.10 1,330.33 1,295.53 208.82 33.26
P & G Health Ltd 5,259.35 1,166.89 1,151.26 36.90 39.76
Glaxosmi. Pharma 2,776.60 3,530.73 3,407.25 55.21 44.44
Cipla 1,452.70 17,645.00 16,574.34 24.90 20.10
Amrutanjan Healt 645.10 437.58 421.23 37.81 20.84
Fermenta Biotec. 292.05 315.24 307.09 27.68 4.10
Guj. Themis Bio. 272.20 174.19 169.82 56.36 44.82
Bliss GVS Pharma 120.00 638.96 605.46 27.46 11.19
Ambalal Sarabhai 37.31 11.70 3.81 15.94 1.92